Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Sponsor: National Institutes of Health (NIH)
Terminated
Recruitment was slower than anticipated. Incomplete neuropsychological outcome measures obtained.
Other terminated trials from National Institutes of Health (NIH)
- Adolescent Behavior · Phase PHASE2 · Mar 2025
- Diet, Food Choice, Taste · Phase NA · Dec 2021
- Clostridium Difficile · Phase PHASE2 · Sep 2021
- Epilepsy · May 2020
- Failed Back Surgery Syndrome · Phase NA · Mar 2020
See all terminations from National Institutes of Health (NIH)
Other Traumatic Brain Injury trials with similar outcome
This PHASE2 trial investigates Traumatic Brain Injury and is currently terminated or withdrawn. National Institutes of Health (NIH) leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 5 earlier versions
-
Nov 2018 — Nov 2020 [monthly]
Terminated PHASE2
Status: Unknown Status → Terminated
-
Jun 2018 — Nov 2018 [monthly]
Unknown Status PHASE2
-
Jul 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
Status: Not Yet Recruiting → Unknown Status
-
Feb 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institutes of Health (NIH)
- Uniformed Services University of the Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .